About the author: |
A. T. Badalova, A. J. Aliyeva, S. H. Aliyev, Sh. M. Huseynova, J. T. Aliyeva, S. I. Hajiyeva, N. A. Jafarova |
Heading |
EXPERIMENTAL MEDICINE |
Type of article |
Scentific article |
Annotation |
Diabetes mellitus is one of the important medical and social problems facing the healthcare systems of all countries of the world. Dyslipidemia plays a significant role in the pathogenesis of vascular complications of the disease. In this regard, correction of blood lipid composition is inevitable. To contribute to the solution of the problem, we conducted an experimental study on 21 rabbits. Blood lipid parameters were studied against the background of the combined effect of atorvastatin and hawthorn during experimental diabetes. It was found that when atorvastatin is used together with phytotherapy, the amount of atherogenic lipoproteins decreases sharply, and the level of anti-atherogenic lipoproteins increases. It can be concluded that it is recommended to add phytotherapy with statins to the dyslipidemia correction protocol. |
Tags |
diabetes mellitus,total cholesterol,triglycerides,lipoproteins,five-toothed hawthorn |
Bibliography |
- Athyros VG, Doumas M, Imprialos KP, Stavropoulos K, Georgianou E, Katsimardou A, Karagiannis A. Diabetes and lipid metabolism. Hormones (Athens). 2018 Mar;17(1):61-67. https://doi.org/10.1007/s42000-018-0014-8.
- Badalova AT, Aliyeva JT. Correction of hemostasis disorders in experimental diabetes with antidiabetic lymphotropic complex. Azerbaijan Pharmaceutical and Pharmacotherapy Journal, №1, 2023, p. 86. https://doi.org/10.58495/XHPA4451.
- Demir S, Nawroth PP, Herzig S, Ekim Üstünel B. Emerging targets in type 2 diabetes and diabetic complications. Advanced Science (Weinh). 2021 Sep;8(18): e2100275. https://doi.org/10.1002/advs.202100275.
- Dilworth L, Facey A, Omoruyi F. Diabetes Mellitus and Its Metabolic Complications: The Role of Adipose Tissues. International Journal of Molecular Sciences. 2021, 22, 7644. https://doi.org/10.3390/ijms22147644.
- Duran EK, Aday AW, Cook NR, Buring JE, Ridker PM, Pradhan AD. Triglyceride-rich lipoprotein cholesterol, small dense LDL cholesterol, and incident cardiovascular disease. Journal of the American College of Cardiology. 2020 May 5;75(17):2122-2135. https://doi.org/10.1016/j.jacc.2020.02.059.
- Filippatos T, Tsimihodimos V, Pappa E, Elisaf M. Pathophysiology of diabetic dyslipidaemia, Current Vascular Pharmacology. 2017; 15(6):566-575. https://doi.org/10.2174/1570161115666170201105425.
- Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019; 62(1):3-16. https://doi.org/10.1007/s00125-018-4711-2.
- John PK, Clive RP, Ira DG, Mary JM. Dyslipidemia and diabetes mellitus: Role of lipoprotein species and interrelated pathways of lipid metabolism in diabetes mellitus. Current Opinion in Pharmacology, Volume 61, December 2021, Pages 21-27. https://doi.org/10.1016/j.coph.2021.08.013.
- Papatheodorou K, Banach M, Bekiari E, Rizzo M, Edmonds M. Complications of Diabetes 2017. Journal of Diabetes Research. 2018 Mar 11; 2018:3086167. https://doi.org/10.1155/2018/3086167.
- Williams R, Colagiuri S, Chan J, Gregg E, Ke C, Lim L-L, et al. International Diabetes Federation Atlas 9th Edition. 2019. 176 p.
|
Publication of the article |
«World of Medicine and Biology» №1(91), 2025 year, 141-144 pages, index UDK 616.379-008.64-03-092.9 |
DOI |
10.26724/2079-8334-2025-1-91-141-144 |